Hayat Pharmaceutical Industries Co. PLC (ASE: HPIC)
Jordan
· Delayed Price · Currency is JOD 2.620
+0.020 (0.77%)
At close: Nov 17, 2024
HPIC Income Statement
Financials in millions JOD. Fiscal year is January - December.
Millions JOD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 16.42 | 15.81 | 17.11 | 16.58 | 16.58 | 15.64 | Upgrade
|
| Revenue Growth (YoY) | 6.46% | -7.61% | 3.15% | 0.02% | 5.99% | 10.80% | Upgrade
|
| Cost of Revenue | 6.33 | 5.93 | 6.01 | 5.39 | 5.2 | 5.65 | Upgrade
|
| Gross Profit | 10.09 | 9.88 | 11.09 | 11.19 | 11.38 | 9.99 | Upgrade
|
| Selling, General & Admin | 6.06 | 6.36 | 6.45 | 6.21 | 6.7 | 5.59 | Upgrade
|
| Research & Development | 0.68 | 0.66 | 0.58 | 0.47 | 0.35 | 0.37 | Upgrade
|
| Other Operating Expenses | -0.24 | 0.02 | -0.14 | -0.05 | -0.05 | -0.08 | Upgrade
|
| Operating Expenses | 6.51 | 7.04 | 6.89 | 6.77 | 7.2 | 5.88 | Upgrade
|
| Operating Income | 3.58 | 2.84 | 4.2 | 4.42 | 4.19 | 4.11 | Upgrade
|
| Interest Expense | -0.12 | -0.1 | -0.07 | -0.09 | -0.11 | -0.12 | Upgrade
|
| EBT Excluding Unusual Items | 3.45 | 2.74 | 4.14 | 4.33 | 4.08 | 3.99 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | -0.24 | Upgrade
|
| Pretax Income | 3.45 | 2.74 | 4.14 | 4.33 | 4.08 | 3.75 | Upgrade
|
| Income Tax Expense | 0.51 | 0.41 | 0.61 | 0.69 | 0.57 | 0.42 | Upgrade
|
| Net Income | 2.95 | 2.33 | 3.53 | 3.64 | 3.51 | 3.33 | Upgrade
|
| Net Income to Common | 2.95 | 2.33 | 3.53 | 3.64 | 3.51 | 3.33 | Upgrade
|
| Net Income Growth | 32.30% | -34.04% | -3.12% | 3.75% | 5.36% | 5.99% | Upgrade
|
| Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 3.55% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.30 | 0.25 | 0.37 | 0.38 | 0.37 | 0.35 | Upgrade
|
| EPS (Diluted) | 0.30 | 0.25 | 0.37 | 0.38 | 0.37 | 0.35 | Upgrade
|
| EPS Growth | 27.77% | -34.04% | -3.12% | 3.75% | 5.36% | 5.99% | Upgrade
|
| Free Cash Flow | 0.43 | 2.44 | 2.23 | 3.95 | 3.05 | 1.08 | Upgrade
|
| Free Cash Flow Per Share | 0.04 | 0.26 | 0.24 | 0.42 | 0.32 | 0.11 | Upgrade
|
| Dividend Per Share | 0.165 | 0.165 | 0.250 | 0.250 | 0.200 | 0.100 | Upgrade
|
| Dividend Growth | -34.00% | -34.00% | 0% | 25.00% | 100.00% | - | Upgrade
|
| Gross Margin | 61.45% | 62.50% | 64.85% | 67.48% | 68.65% | 63.88% | Upgrade
|
| Operating Margin | 21.79% | 17.96% | 24.58% | 26.67% | 25.25% | 26.28% | Upgrade
|
| Profit Margin | 17.94% | 14.73% | 20.63% | 21.96% | 21.17% | 21.30% | Upgrade
|
| Free Cash Flow Margin | 2.65% | 15.45% | 13.07% | 23.80% | 18.39% | 6.88% | Upgrade
|
| EBITDA | 4.69 | 3.93 | 5.26 | 5.32 | 4.67 | 4.57 | Upgrade
|
| EBITDA Margin | 28.56% | 24.84% | 30.74% | 32.09% | 28.14% | 29.24% | Upgrade
|
| D&A For EBITDA | 1.11 | 1.09 | 1.05 | 0.9 | 0.48 | 0.46 | Upgrade
|
| EBIT | 3.58 | 2.84 | 4.2 | 4.42 | 4.19 | 4.11 | Upgrade
|
| EBIT Margin | 21.79% | 17.96% | 24.58% | 26.67% | 25.25% | 26.27% | Upgrade
|
| Effective Tax Rate | 14.70% | 15.07% | 14.68% | 15.91% | 13.96% | 11.14% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.